Compare Stocks → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CTRVOTCMKTS:ETSTOTCMKTS:PXYNNASDAQ:TRPX Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTRVContraVir Pharmaceuticals$1.37-0.7%$3.11$3.52▼$91.00$1.10M1.16432,822 shs12,853 shsETSTEarth Science Tech$0.09-10.0%$0.07$0.00▼$0.12$27.90M1.64115,749 shs163,332 shsPXYNPraxsyn$0.00$0.00▼$0.01$85K-1.01N/AN/ATRPXTherapix Biosciences$0.10$0.23$0.25▼$4.69$351KN/A1.59 million shs95,212 shs10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTRVContraVir Pharmaceuticals-5.48%+0.73%-45.24%-12.66%+112.05%ETSTEarth Science Tech-10.00%-10.00%+57.89%+40.63%+126.13%PXYNPraxsyn0.00%0.00%0.00%0.00%0.00%TRPXTherapix Biosciences0.00%0.00%0.00%0.00%0.00%The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTRVContraVir PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AETSTEarth Science TechN/AN/AN/AN/AN/AN/AN/AN/APXYNPraxsynN/AN/AN/AN/AN/AN/AN/AN/ATRPXTherapix BiosciencesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTRVContraVir PharmaceuticalsN/AN/AN/AN/AETSTEarth Science TechN/AN/AN/AN/APXYNPraxsynN/AN/AN/AN/ATRPXTherapix BiosciencesN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTRVContraVir PharmaceuticalsN/AN/AN/AN/A$0.80 per shareN/AETSTEarth Science Tech$50K557.96N/AN/AN/A∞PXYNPraxsynN/AN/AN/AN/AN/AN/ATRPXTherapix BiosciencesN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTRVContraVir Pharmaceuticals-$9.45MN/A0.00∞N/AN/A-4,810.77%-130.14%N/AETSTEarth Science Tech-$370KN/A0.00∞N/A5.77%20.61%11.73%N/APXYNPraxsynN/AN/A0.00N/AN/AN/AN/AN/AN/ATRPXTherapix Biosciences-$4.79MN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTRVContraVir PharmaceuticalsN/AN/AN/AN/AN/AETSTEarth Science TechN/AN/AN/AN/AN/APXYNPraxsynN/AN/AN/AN/AN/ATRPXTherapix BiosciencesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTRVContraVir PharmaceuticalsN/A0.550.55ETSTEarth Science Tech0.100.870.39PXYNPraxsynN/AN/AN/ATRPXTherapix BiosciencesN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTRVContraVir Pharmaceuticals1.07%ETSTEarth Science TechN/APXYNPraxsynN/ATRPXTherapix Biosciences14.32%Insider OwnershipCompanyInsider OwnershipCTRVContraVir Pharmaceuticals1.60%ETSTEarth Science Tech24.90%PXYNPraxsynN/ATRPXTherapix BiosciencesN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCTRVContraVir Pharmaceuticals14800,000N/ANot OptionableETSTEarth Science Tech8309.98 million232.80 millionNot OptionablePXYNPraxsyn66847.94 millionN/ANot OptionableTRPXTherapix Biosciences93.51 millionN/ANot OptionableCTRV, TRPX, ETST, and PXYN HeadlinesSourceHeadlineAnixa Biosciences Stock (NASDAQ:ANIX), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 12 at 5:48 AMSagimet Biosciences Inc (SGMT)investing.com - August 23 at 7:29 AMPBIO Pressure BioSciences, Inc.seekingalpha.com - August 1 at 3:24 PMCannabis, Coats, and Social Media: The Good, Bad, and Ugly of 2017's IPOsthestreet.com - January 19 at 7:59 PMMedia Sentiment Over TimeCompany DescriptionsContraVir PharmaceuticalsNASDAQ:CTRVContraVir Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. It engages in the development of TXL, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of Hepatitis B; and CRV431, a novel drug candidate for the treatment of chronic HBV infection. The company was founded in 2013 and is headquartered in Edison, New Jersey.Earth Science TechOTCMKTS:ETSTEarth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.PraxsynOTCMKTS:PXYNPraxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers' compensation system, as well as preferred provider contracts. The company was formerly known as The PAWS Pet Company, Inc. and changed its name to Praxsyn Corporation in March 2014. Praxsyn Corporation was founded in 2005 and is headquartered in Las Vegas, Nevada.Therapix BiosciencesNASDAQ:TRPX Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.